A landmark French trial will seek to settle one of the country’s biggest pharmaceutical scandals, probing whether the company behind a weight-loss drug believed to have triggered killer side effects covered up the risks.
GlaxoSmithKline will change incentives for sales representatives in some countries as the British drugmaker looks to retain talent.
China has banned drug wholesalers from selling vaccines after a scandal in which about $90-million worth of illegal vaccines was suspected of being sold in dozens of provinces.
RALEIGH, N.C. – Although GlaxoSmithKline (GSK) employs thousands in North Carolina and the United States, it’s unlikely that any U.S. operation will have a say in who the company’s next chief executive officer will be if Andrew Witty leaves the position, the Triangle Business Journal reported this morning. In recent days, some of the […]
China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population. Given the 10 years or more it typically takes to bring a new medicine to market, original “Made in […]
The big worries on growth hanging over the pharmaceuticals industry are poles apart. Pressure on U.S. drug pricing is casting a shadow over the sector’s most lucrative market. But slowing emerging-market growth, notably in China, shouldn’t be ignored. Emerging-market sales for the big pharmaceuticals firms tracked by Sanford C. Bernstein increased by about 5.5%, year […]